Treatment-resistant-depression

CARLAT WEBINAR

ECT: Update and Comprehensive Review

November 3, 2022

Advances in ECT have made it safer, more comfortable, and with a better cognitive profile that allowed for its use other than just as a last resort.

What Gets in the Way of Antidepressants?

August 1, 2022

Chris Aiken, MD and Garrett Rossi, MD.

Garrett Rossi, MD.
Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Chris Aiken, MD.
Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Rossi and Dr. Aiken, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Recent research has added to our understanding of factors that inhibit response to treatment, including major stress, nonadherence, and anxiety.

12 New Findings on Quetiapine

June 6, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

12 clinically relevant findings from the past 3 years on quetiapine (Seroquel), including new side effects, dosing strategies, withdrawal phenomena, and new uses in bipolar with OCD.

Can TMS Turn on the Switch?

June 1, 2022

Edmund S. Higgins, MD.

Edmund S. Higgins, MD. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Most antidepressant therapies can induce mania, and this study looks at whether TMS belongs on that list. We report on the latest findings.

Tricyclic Antidepressants: When and How to Use Them

May 1, 2022

Edmund S. Higgins, MD. Clinical associate professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Tricyclics have been used in psychiatry since the 1950s, when imipramine was introduced as the first mass-marketed antidepressant. Fluoxetine and the other SSRIs largely supplanted the tricyclics in the 1990s, but these medications still have their uses.

Structural Brain Changes After ECT for Depression

April 5, 2022

Chris Aiken, MD and Batya Swift Yasgur, MA, LSW

Chris Aiken, MD Batya Swift Yasgur, MA, LSW The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How does ECT change the brain? A systemic review offers up some answers.

Psilocybin vs Escitalopram for Depression

September 10, 2021

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin is inching its way toward FDA approval in depression, but will this trial from the New England Journal of Medicine help it along or set it back?

Pilot Study of Ketamine vs ECT for Major Depression

September 10, 2021

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The first head-to-head comparison reveals a subtle difference between these two therapies

ECT Worked: Now What?

August 3, 2021

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Your patient has recovered from depression with ECT, but their chances of going back into it are high (80%). In this article, learn 3 ways to reduce that risk.

Psychotherapy and Medication in Recurrent Depression

June 29, 2021

Giovanni Fava, MD

Giovanni Fava, MD

Clinical Professor of Psychiatry at the State University of New York at Buffalo. Editor-in-Chief of the journal Psychotherapy and Psychosomatics and author of over 500 scientific papers. His book, Discontinuing Antidepressant Medications, is due from Oxford University Press in 2021. Dr. Fava has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressants treat depression, but patients need something more to prevent future episodes. Giovanni Fava describes an evidence-based method that blends medication with psychotherapy in two phases: sequential treatment for prevention of depression.